ARSHAD AZIZ: Open Payments
NPI 1407221286 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$883 in 46 payments from 12 companies in 2025. Trend: 2023 $1,026 · 2024 $1,873 · 2025 $883
Food & beverage: $883
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 6 | $163 |
| UCB, Inc. | 12 | $156 |
| ABBVIE INC. | 10 | $154 |
| Alexion Pharmaceuticals, Inc. | 3 | $81 |
| ACADIA Pharmaceuticals Inc | 3 | $73 |
| PFIZER INC. | 4 | $73 |
| Neurelis, Inc. | 2 | $51 |
| Lilly USA, LLC | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Amneal Pharmaceuticals LLC | 1 | $24 |
Products named: Leqembi, Briviact, NUPLAZID, NURTEC ODT, QULIPTA, VYALEV, Nayzilam, ULTOMIRIS.
Industry payments across AZ — which companies pay providers there.
